Bottom line Mounjaro (tirzepatide) is a GLP-1 and GIP dual receptor agonist containing the same active ingredient as Zepbound, a weight loss drug made by the same manufacturer, Novo Nordisk
Since these two pathways were previously identified as crucial in the AD-related pathway-gene network, we performed cluster analysis on the union of DEGs from all four groups involved in either Neuroactive ligand-receptor interaction or Calcium signaling pathway
For background on how to interpret peptide research literature, see our peptide glossary, which defines terms such as EC50, receptor affinity, and bioavailability
Bisdemethoxycurcumin attenuates cisplatin-induced renal injury through anti-apoptosis, anti-oxidant and anti-inflammatory
Mechanical stress and increased anterior tibial translation can generate reactive oxygen species (ROS), which are chemically reactive molecules containing oxygen
Aging, Biomarker, Consortium et al